Sam Altman is reportedly entering in brain-computer interface domain through a new startup, Merge Labs. The company is ...

Microsoft (NASDAQ:MSFT)-backed OpenAI co-founder Sam Altman is gearing up to back Merge Labs, a new brain-computer interface startup that could go head-to-head with Elon Musk's Neuralink, the ...

Neuralink is a dominant force in the BCI space, but the arrival of a new, well-capitalised startup in Merge Labs may change the conversation.

The Financial Times reports today that Sam Altman has OpenAI planning to invest in a new brain-computer interface (BCI) venture, Merge Labs.

Sam Altman, the OpenAI co-founder valued at the center of artificial intelligence's rapid ascent, is preparing a challenge to ...

Merge Labs is a new Neuralink rival developing brain-computer interfaces. If you’ve enjoyed Elon Musk’s ongoing beef with ...

The brain chip company that has drawn interest from Sam Altman and his artificial intelligence business OpenAI is exploring ...

In a strategic move, OpenAI CEO Sam Altman is reportedly planning to invest in a brain implant startup, called Merge Labs, ...

Microsoft (MSFT)-backed OpenAI's latest venture, Merge Labs, is looking to develop a novel gene therapy approach targeting ...

Sam Altman is launching Merge Labs, an $850 million brain-computer interface startup, potentially funded by OpenAI's ventures ...

Sam Altman is planning a brain implant startup to rival Elon Musk’s Neuralink: OpenAI is planning to invest in a brain ...

OpenAI CEO Sam Altman is in talks to co-found Merge Labs, a potential $850M brain–computer interface startup rivaling Elon ...